Friday, December 25, 2009, 11:25PM AEST - The Australian Stockmarket is closed.
To create a watchlist or portfolio of shares, Register

Sigma-Aldrich Corporation (SIAL)

5:00AM AEST: 51.14 USD  Up 0.10 (0.20%)  
 MORE ON SIAL 
Quotes
HereSummary
Charts
Technical Analysis
News & Info
Company
Analyst Coverage
Ownership
Financials
 Sigma-Aldrich Corporation (NasdaqNM:SIAL) Delayed quote dataEdit
Last Trade:51.14 USD
Trade Time: 5:00AM AEST
Change:Up 0.10 (0.20%)
Prev Close:51.04
Open:51.07
Bid:42.83 x 400
Ask:N/A
1y Target Est:60.00
Day's Range:50.87 - 51.36
52wk Range:31.45 - 56.29
Volume:170,765
Avg Vol (3m):658,845
Market Cap:6.22B
P/E (ttm):18.73
EPS (ttm):2.73
Div & Yield:0.58 (1.14%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
 Add SIAL to Portfolio   Download Data

 HEADLINES 
Sigma-Aldrich Enters Oversold Territory
Zacks.com (Fri 2:51AM)
Sigma-Aldrich to Present at the 28th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2010
PR Newswire (Wed, Dec 23)
5-Star Stocks Poised to Pop: Sigma-Aldrich
at Motley Fool (Tue, Dec 8)
Sigma-Aldrich’s rat breakthrough hailed as top innovation
at bizjournals.com (Fri, Dec 4)
Sigma-Aldrich's Targeted Knockout Rat Ranks in Top Five of The Scientist Magazine's Top 10 Innovations of 2009
PR Newswire (Fri, Dec 4)
Sell Cu, Buy Au, Ag, K2CO3
Wall Street Transcript (Thu, Dec 3)
Sigma-Aldrich to Present at the NASDAQ OMX 23rd Investor Program on Tuesday, December 1, 2009
PR Newswire (Wed, Nov 25)
Sigma-Aldrich Launches 'What's Your Favorite Gene?' Application On Facebook(R) Platform
PR Newswire (Thu, Nov 19)
SIGMA ALDRICH CORP Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year
EDGAR Online (Wed, Nov 18)
Sigma-Aldrich (Nasdaq: SIAL) Declares Quarterly Dividend
PR Newswire (Wed, Nov 11)
Sigma-Aldrich Enters Distribution Agreement With Stemgent, Inc. to Offer Lentivirus-Based Gene Delivery Products for Regenerative Medicine and Stem Cell Research
PR Newswire (Wed, Nov 11)
More Headlines for SIAL...

 ANALYST 
EPS Est (next year) (Dec-09) :2.77
EPS Est (in 2 years) (Dec-10) :3.13
Avg Rec (current)*:2.6
PEG Ratio:2.06
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Sigma-Aldrich Corporation, together with its subsidiaries, develops, manufactures, purchases, and distributes various biochemicals and organic chemicals worldwide.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News7 Indices